Morphine suppresses intracellular interferon-α expression in neuronal cells

Journal of Neuroimmunology

Volumn 199, Issue 1-2, 2008, Pages 1-9

  Wan, Qi ^a,c   Wang, Xu ^a   Wang, Yan Jian ^a   Song, Li ^a   Wang, Shi Hong ^b   Ho, Wen Zhe ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IFN ; Interferon regular factor; Morphine; Naltrexone; NT2 N

Indexed keywords

ALPHA INTERFERON; CYTOKINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MORPHINE; NALTREXONE; OPIATE ANTAGONIST; STAT1 PROTEIN;

ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ANTAGONISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; NERVE CELL; NEUROIMMUNOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BLOTTING, WESTERN; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INTERFERON TYPE II; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEURONS; PROMOTER REGIONS (GENETICS); RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 47749113634     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.04.026     Document Type: Article

References (69)

1. Aguet M. High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature 284 (1980) 459-461
2. Aguet M., and Mogensen K.E. Interferon receptors. Interferon 5 (1983) 1-22
3. Au W.C., and Pitha P.M. Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon a promoters. J. Biol. Chem. 276 (2001) 41629-41637
4. Bani-Yaghoub M., Felker J.M., Ozog M.A., Bechberger J.F., and Naus C.C. Array analysis of the genes regulated during neuronal differentiation of human embryonal cells. Biochem. Cell. Biol. 79 (2001) 387-398
5. Barnes B.J., Moore P.A., and Pitha P.M. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276 (2001) 23382-23390
6. Barnes B., Lubyova B., and Pitha P.M. On the role of IRF in host defense. J. Interferon Cytokine Res. 22 (2002) 59-71
7. Barton G.M., and Medzhitov R. Linking toll-like receptors to IFN-alpha/beta expression. Nat. Immunol. 4 (2003) 432-433
8. Baumhaker Y., Gafni M., Keren O., and Sarne Y. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44 (1993) 461-467
9. Bayer B.M., Daussin S., Hernandez M., and Irvin L. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology 29 (1990) 369-374
10. Bigliardi P.L., Sumanovski L.T., Buchner S., Rufli T., and Bigliardi-Qi M. Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression. J. Invest. Dermatol. 120 (2003) 145-152
11. Bigliardi-Qi M., Bigliardi P.L., Eberle A.N., Buchner S., and Rufli T. beta-endorphin stimulates cytokeratin 16 expression and downregulates mu-opiate receptor expression in human epidermis. J. Invest. Dermatol. 114 (2000) 527-532
12. Bigliardi-Qi M., Sumanovski L.T., Buchner S., Rufli T., and Bigliardi P.L. Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology 209 (2004) 183-189
13. Carpenter G.W., Garza Jr. H.H., Gebhardt B.M., and Carr D.J. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain Behav. Immun. 8 (1994) 185-203
14. Carr D.J., and Serou M. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31 (1995) 59-71
15. Chakrabarti S., Yang W., Law P.Y., and Loh H.H. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol. Pharmacol. 52 (1997) 105-113
16. Chang S.L., Wu G.D., Patel N.A., Vidal E.L., and Fiala M. The effects of interaction between morphine and interleukin-1 on the immune response. Adv. Exp. Med. Biol. 437 (1998) 67-72
17. Cohen G.B., Gandhi R.T., Davis D.M., Mandelboim O., Chen B.K., Strominger J.L., and Baltimore D. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10 (1999) 661-671
18. Dafny N. Is interferon-alpha a neuromodulator?. Brain Res. Brain. Res. Rev. 26 (1998) 1-15
19. Delhaye S., Paul S., Blakqori G., Minet M., Weber F., Staeheli P., and Michiels T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 7835-7840
20. Eisenstein T.K., and Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J. Neuroimmunol. 83 (1998) 36-44
21. Eisenstein T.K., Bussiere J.L., Rogers T.J., and Adler M.W. Immunosuppressive effects of morphine on immune responses in mice. Adv. Exp. Med. Biol. 335 (1993) 41-52
22. Fecho K., Maslonek K.A., Dykstra L.A., and Lysle D.T. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276 (1996) 626-636
23. Ferrari A., Ehler E., Nitsch R.M., and Gotz J. Immature human NT2 cells grafted into mouse brain differentiate into neuronal and glial cell types. FEBS Lett. 486 (2000) 121-125
24. Friedman H., and Eisenstein T.K. Neurological basis of drug dependence and its effects on the immune system. J. Neuroimmunol. 147 (2004) 106-108
25. Gazziola C., Cordani N., Carta S., De Lorenzo E., Colombatti A., and Perris R. The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells. Int. J. Oncol. 26 (2005) 129-140
26. Geber W.F., Lefkowitz S.S., and Hung C.Y. Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Arch. Int. Pharmacodyn. Ther. 214 (1975) 322-327
27. Guillemain I., Alonso G., Patey G., Privat A., and Chaudieu I. Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. J. Comp. Neurol. 422 (2000) 380-395
28. Guo C.J., Douglas S.D., Gao Z., Wolf B.A., Grinspan J., Lai J.P., Riedel E., and Ho W.Z. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes. Glia 48 (2004) 259-266
29. Hassan N.F., Campbell D.E., and Douglas S.D. Purification of human monocytes on gelatin-coated surfaces. J. Immunol. Methods 95 (1986) 273-276
30. Hauser K.F., El-Hage N., Stiene-Martin A., Maragos W.F., Nath A., Persidsky Y., Volsky D.J., and Knapp P.E. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J. Neurochem. 100 (2007) 567-586
31. Hernandez M.C., Flores L.R., and Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267 (1993) 1336-1341
32. Homan J.W., Steele A.D., Martinand-Mari C., Rogers T.J., Henderson E.E., Charubala R., Pfleiderer W., Reichenbach N.L., and Suhadolnik R.J. Inhibition of morphine-potentiated HIV-1 replication in peripheral blood mononuclear cells with the nuclease-resistant 2-5A agonist analog, 2-5A(N6B). J. Acquir. Immune. Defic. Syndr. 30 (2002) 9-20
33. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., and Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 (2005) 772-777
34. Horner K.A., and Zadina J.E. Internalization and down-regulation of mu opioid receptors by endomorphins and morphine in SH-SY5Y human neuroblastoma cells. Brain Res. 1028 (2004) 121-132
35. Hung C.Y., Lefkowitz S.S., and Geber W.F. Interferon inhibition by narcotic analgesics. Proc. Soc. Exp. Biol. Med. 142 (1973) 106-111
36. Kapadia F., Vlahov D., Donahoe R.M., and Friedland G. The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin. Infect. Dis. 41 (2005) 1027-1034
37. Kelschenbach J., Barke R.A., and Roy S. Morphine withdrawal contributes to Th cell differentiation by biasing cells toward the Th2 lineage. J. Immunol. 175 (2005) 2655-2665
38. Lafon M., Prehaud C., Megret F., Lafage M., Mouillot G., Roa M., Moreau P., Rouas-Freiss N., and Carosella E.D. Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J. Virol. 79 (2005) 15226-15237
39. Langer J., Garotta G., and Pestka S. Interferon receptors. Biotherapy 8 (1996) 163-174
40. Law P.Y., and Loh H.H. Regulation of opioid receptor activities. J. Pharmacol. Exp. Ther. 289 (1999) 607-624
41. Li Y., Wang X., Tian S., Guo C.J., Douglas S.D., and Ho W.Z. Methadone enhances human immunodeficiency virus infection of human immune cells. J. Infect. Dis. 185 (2002) 118-122
42. Li Y., Douglas S.D., Pleasure D.E., Lai J., Guo C., Bannerman P., Williams M., and Ho W. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression. J. Neurosci. Res. 71 (2003) 559-566
43. Li Y., Ye L., Peng J.S., Wang C.Q., Luo G.X., Zhang T., Wan Q., and Ho W.Z. Morphine inhibits intrahepatic interferon-alpha expression and enhances complete hepatitis C virus replication. J. Infect. Dis. 196 (2007) 719-730
44. Lin R., Mamane Y., and Hiscott J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 275 (2000) 34320-34327
45. Lockwood L.L., Silbert L.H., Fleshner M., Laudenslager M.L., Watkins L.R., and Maier S.F. Morphine-induced decreases in in vivo antibody responses. Brain Behav. Immun. 8 (1994) 24-36
46. Loh H.H., and Smith A.P. Molecular characterization of opioid receptors. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 123-147
47. Marie I., Durbin J.E., and Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17 (1998) 6660-6669
48. McCarthy L., Wetzel M., Sliker J.K., Eisenstein T.K., and Rogers T.J. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62 (2001) 111-123
49. Nair M.P., Schwartz S.A., Polasani R., Hou J., Sweet A., and Chadha K.C. Immunoregulatory effects of morphine on human lymphocytes. Clin. Diagn. Lab. Immunol. 4 (1997) 127-132
50. Novick D.M., Ochshorn M., Ghali V., Croxson T.S., Mercer W.D., Chiorazzi N., and Kreek M.J. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J. Pharmacol. Exp. Ther. 250 (1989) 606-610
51. Ochshorn M., Novick D.M., and Kreek M.J. In vitro studies of the effect of methadone on natural killer cell activity. Isr. J. Med. Sci. 26 (1990) 421-425
52. Pestka S., Langer J.A., Zoon K.C., and Samuel C.E. Interferons and their actions. Annu. Rev. Biochem. 56 (1987) 727-777
53. Peterson P.K., Sharp B., Gekker G., Brummitt C., and Keane W.F. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells. J. Clin. Invest. 80 (1987) 824-831
54. Peterson P.K., Gekker G., Brummitt C., Pentel P., Bullock M., Simpson M., Hitt J., and Sharp B. Suppression of human peripheral blood mononuclear cell function by methadone and morphine. J. Infect. Dis. 159 (1989) 480-487
55. Peterson P.K., Molitor T.W., and Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem. Pharmacol. 46 (1993) 343-348
56. Pleasure S.J., Page C., and Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 12 (1992) 1802-1815
57. Prehaud C., Megret F., Lafage M., and Lafon M. Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79 (2005) 12893-12904
58. Risdahl J.M., Khanna K.V., Peterson P.K., and Molitor T.W. Opiates and infection. J. Neuroimmunol. 83 (1998) 4-18
59. Roy S., Cain K.J., Chapin R.B., Charboneau R.G., and Barke R.A. Morphine modulates NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun. 245 (1998) 392-396
60. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55 (2001) 255-281
61. Shi X G.N., Guo Q.M., Yang Y.J., Huo M.D., Hu H.L., and Friess H. Relationship between overexpression of NK-1R, NK-2R and intestinal mucosal damage in acute necrotizing pancreatitis. World J. Gastroenterol. 9 (2003) 160-164
62. Stoll-Keller F., Schmitt C., Thumann C., Schmitt M.P., Caussin C., and Kirn A. Effects of morphine on purified human blood monocytes. Modifications of properties involved in antiviral defences. Int. J. Immunopharmacol. 19 (1997) 95-100
63. Wan Q., Douglas S.D., Wang X., Kolson D.L., O'Donnell L.A., and Ho W.Z. Morphine upregulates functional expression of neurokinin-1 receptor in neurons. J. Neurosci. Res. 84 (2006) 1588-1596
64. Wang J., Charboneau R., Balasubramanian S., Barke R.A., Loh H.H., and Roy S. The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J. Leukoc. Biol. 71 (2002) 782-790
65. Wang J., Barke R.A., Charboneau R., Loh H.H., and Roy S. Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J. Biol. Chem. 278 (2003) 37622-37631
66. Wang X., Douglas S.D., Commons K.G., Pleasure D.E., Lai J., Ho C., Bannerman P., Williams M., and Ho W. A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neurons. J. Neurosci. Res. 75 (2004) 544-553
67. Wang C.Q., Li Y., Douglas S.D., Wang X., Metzger D.S., Zhang T., and Ho W.Z. Morphine withdrawal enhances hepatitis C virus replicon expression. Am. J. Pathol. 167 (2005) 1333-1340
68. Zaki N.G., Osman A., Moustafa H., and Saad A.H. Alterations of immune functions in heroin addicts. Egypt. J. Immunol. 13 (2006) 153-171
69. Zhang S., Tong Y., Tian M., Dehaven R.N., Cortesburgos L., Mansson E., Simonin F., Kieffer B., and Yu L. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family. J. Pharmacol. Exp. Ther. 286 (1998) 136-141